Eyetamins is a healthcare technology and life sciences company focused on therapeutics and consumer innovations in the $200B eye health and wellness space. They launched the company with natural supplements for eye health, which is a $37B industry. They have a patent-pending formula for dry eye, which is an $8B untapped market.
Geoffrey Colby, MD, PhD is a neurosurgeon and expert specialist in the open microsurgical and minimally-invasive endovascular treatment of cerebrovascular disorders of the brain...
Matt Patsky is CEO and Lead Portfolio Manager of the Trillium ESG Global Equity strategy and Portfolio Manager of the Trillium Sustainable Opportunities strategy....
Dr. Krell is a fascinating general dentist with a combined business background. He is currently the Head of Marketing at Simplifeye, based in NYC,...
